Investing Experience -
Risk Profile -
Followers
0
Following
0
Blog Posts
0
Threads
5,968
Blogs
Threads
Portfolio
Follower
Following
Summary
Total comments
5,968
Past 30 days
0
Past 7 days
0
Today
0
User Comments
Stock
2020-10-22 11:02 | Report Abuse
What happening for RHB nowaday !!!......
Why Bluechip become RedChip....kekeke......
Why Bluechip become Blue-Shit......kekeke......
Time to wake up lorr....
No more traditional bluechip liao......
No matter local or foreign institutions....all swift their funds to more defensive stocks not affected by pandemic & political uncertainty...
Wake up lorrr............
Stock
2020-10-22 11:01 | Report Abuse
What happening IHH nowaday !!!......
Why Bluechip become RedChip....kekeke......
Why Bluechip become Blue-Shit......kekeke......
Time to wake up lorr....
No more traditional bluechip liao......
No matter local or foreign institutions....all swift their funds to more defensive stocks not affected by pandemic & political uncertainty...
Wake up lorrr............
Stock
2020-10-22 10:59 | Report Abuse
What happening today !!!......
Why Bluechip become RedChip....kekeke......
Why Bluechip become Blue-Shit......kekeke......
Time to wake up lorr....
No more traditional bluechip liao......
No matter local or foreign institutions....all swift their funds to more defensive stocks not affected by pandemic & political uncertainty...
Wake up lorrr............
Stock
2020-10-22 10:57 | Report Abuse
What happening for Cimb !!!......
Why Bluechip become RedChip....kekeke......
Why Bluechip become Blue-Shit......kekeke......
Time to wake up lorr....
No more traditional bluechip liao......
No matter local or foreign institutions....all swift their funds to more defensive stocks not affected by pandemic & political uncertainty...
Wake up lorrr............
Stock
2020-10-22 10:56 | Report Abuse
What happening for Genting nowadays !!!......
Why Bluechip become RedChip....kekeke......
Why Bluechip become Blue-Shit......kekeke......
Time to wake up lorr....
No more traditional bluechip liao......
No matter local or foreign institutions....all swift their funds to more defensive stocks not affected by pandemic & political uncertainty...
Wake up lorrr............
Stock
2020-10-22 10:55 | Report Abuse
What happening today !!!......
Why Bluechip become RedChip....kekeke......
Why Bluechip become Blue-Shit......kekeke......
Time to wake up lorr....
No more traditional bluechip liao......
No matter local or foreign institutions....all swift their funds to more defensive stocks not affected by pandemic & political uncertainty...
Wake up lorrr............
Stock
2020-10-22 10:55 | Report Abuse
What happening for Axiata !!!......
Why Bluechip become RedChip....kekeke......
Why Bluechip become Blue-Shit......kekeke......
Time to wake up lorr....
No more traditional bluechip liao......
No matter local or foreign institutions....all swift their funds to more defensive stocks not affected by pandemic & political uncertainty...
Wake up lorrr............
Stock
2020-10-22 10:53 | Report Abuse
What happening today !!!......
Why Bluechip become RedChip....kekeke......
Why Bluechip become Blue-Shit......kekeke......
Time to wake up lorr....
No more traditional bluechip liao......
No matter local or foreign institutions....all swift their funds to more defensive stocks not affected by pandemic & political uncertainty...
Wake up lorrr............
Stock
2020-10-22 08:44 | Report Abuse
R.I.P....to heard that...
AstraZeneca's vaccine still not yet reach the safety consumption level...
Posted by Keyman188 > Oct 22, 2020 8:26 AM | Report Abuse X
AstraZeneca shares turn negative after Brazilian health authority says volunteer in Covid vaccine study dies
(PUBLISHED WED, OCT 21 20201:15 PM EDTUPDATED 35 MIN AGO)
~ AstraZeneca shares turned negative after a Brazilian health authority, Anvisa, said a volunteer in its coronavirus vaccine study died.
~ The Federal University of Sao Paulo, which is helping coordinate late-stage trials in Brazil, separately said that the volunteer was Brazilian, according to Reuters.
~ The news comes as the Food and Drug Administration still has a late-stage clinical trial from AstraZeneca on hold in the United States.
Stock
2020-10-22 08:44 | Report Abuse
R.I.P....to heard that...
AstraZeneca's vaccine still not yet reach the safety consumption level...
Posted by Keyman188 > Oct 22, 2020 8:26 AM | Report Abuse X
AstraZeneca shares turn negative after Brazilian health authority says volunteer in Covid vaccine study dies
(PUBLISHED WED, OCT 21 20201:15 PM EDTUPDATED 35 MIN AGO)
~ AstraZeneca shares turned negative after a Brazilian health authority, Anvisa, said a volunteer in its coronavirus vaccine study died.
~ The Federal University of Sao Paulo, which is helping coordinate late-stage trials in Brazil, separately said that the volunteer was Brazilian, according to Reuters.
~ The news comes as the Food and Drug Administration still has a late-stage clinical trial from AstraZeneca on hold in the United States.
Stock
2020-10-22 08:26 | Report Abuse
AstraZeneca shares turn negative after Brazilian health authority says volunteer in Covid vaccine study dies
(PUBLISHED WED, OCT 21 20201:15 PM EDTUPDATED 35 MIN AGO)
~ AstraZeneca shares turned negative after a Brazilian health authority, Anvisa, said a volunteer in its coronavirus vaccine study died.
~ The Federal University of Sao Paulo, which is helping coordinate late-stage trials in Brazil, separately said that the volunteer was Brazilian, according to Reuters.
~ The news comes as the Food and Drug Administration still has a late-stage clinical trial from AstraZeneca on hold in the United States.
AstraZeneca shares turned negative Wednesday after a Brazilian health authority, Anvisa, said a volunteer in its coronavirus vaccine study died.
The Federal University of Sao Paulo, which is helping coordinate late-stage trials in Brazil, separately said that the volunteer was Brazilian, according to Reuters.
Shares of AstraZeneca, a front-runner in the Covid-19 vaccine race, gave up a slight gain after the news broke. Shares were down by about 1% in early afternoon trading.
A spokesperson from AstraZeneca declined to comment on the volunteer, citing “medical confidentiality and clinical trial regulations.”
The spokesperson added that ”[a]ll significant medical events are carefully assessed by trial investigators” and ”[t]hese assessments have not led to any concerns about continuation of the ongoing study.”
In a statement, a spokesperson from the University of Oxford, which is developing the vaccine with AstraZeneca, said “there have been no concerns about safety of the clinical trial” after an assessment of the case in Brazil.
“The independent review in addition to the Brazilian regulator have recommended that the trial should continue,” Oxford spokesperson Alexander Buxton said.
Oxford provided no further details on the volunteer’s death, and it’s unclear if the volunteer received the vaccine. Brazil currently has the second deadliest outbreak in the world, behind the United States, with at least 115,914 deaths, according to data compiled by Johns Hopkins University.
A source familiar with the situation told Reuters that the trial would have been suspended if the volunteer had been a part of the group getting the shot.
The news comes as the Food and Drug Administration still has a late-stage clinical trial from AstraZeneca on hold in the United States. That means the company is unable to administer second doses of its two-dose vaccine regimen to U.S. participants.
The company announced on Sept. 8 that its trial had been put on hold due to an unexplained illness in a patient in the United Kingdom. The patient is believed to have developed inflammation of the spinal cord, known as transverse myelitis. The trial has since resumed in the U.K. and other countries.
The U.S. is expected to resume the trial as early as this week after the FDA completed its review, Reuters reported Tuesday, citing four anonymous sources.
AstraZeneca is one of four drugmakers backed by the U.S. in late-stage testing for a potential vaccine. AstraZeneca’s vaccine, called AZD1222, uses genetic material from the coronavirus with a modified adenovirus.
In July, the company published data that showed its vaccine produced a promising immune response in an early-stage trial and appeared to be well tolerated.
The vaccine produced no serious adverse events in volunteers, according to the researchers at the time. Fatigue and headache were the most commonly reported side effects, they said. Other common side effects included pain at the injection site, muscle ache, chills and a fever.
##https://www.cnbc.com/2020/10/21/astrazeneca-shares-slide-after-brazilian-health-authority-says-volunteer-in-covid-vaccine-study-dies.html
Stock
2020-10-22 08:26 | Report Abuse
AstraZeneca shares turn negative after Brazilian health authority says volunteer in Covid vaccine study dies
(PUBLISHED WED, OCT 21 20201:15 PM EDTUPDATED 35 MIN AGO)
~ AstraZeneca shares turned negative after a Brazilian health authority, Anvisa, said a volunteer in its coronavirus vaccine study died.
~ The Federal University of Sao Paulo, which is helping coordinate late-stage trials in Brazil, separately said that the volunteer was Brazilian, according to Reuters.
~ The news comes as the Food and Drug Administration still has a late-stage clinical trial from AstraZeneca on hold in the United States.
AstraZeneca shares turned negative Wednesday after a Brazilian health authority, Anvisa, said a volunteer in its coronavirus vaccine study died.
The Federal University of Sao Paulo, which is helping coordinate late-stage trials in Brazil, separately said that the volunteer was Brazilian, according to Reuters.
Shares of AstraZeneca, a front-runner in the Covid-19 vaccine race, gave up a slight gain after the news broke. Shares were down by about 1% in early afternoon trading.
A spokesperson from AstraZeneca declined to comment on the volunteer, citing “medical confidentiality and clinical trial regulations.”
The spokesperson added that ”[a]ll significant medical events are carefully assessed by trial investigators” and ”[t]hese assessments have not led to any concerns about continuation of the ongoing study.”
In a statement, a spokesperson from the University of Oxford, which is developing the vaccine with AstraZeneca, said “there have been no concerns about safety of the clinical trial” after an assessment of the case in Brazil.
“The independent review in addition to the Brazilian regulator have recommended that the trial should continue,” Oxford spokesperson Alexander Buxton said.
Oxford provided no further details on the volunteer’s death, and it’s unclear if the volunteer received the vaccine. Brazil currently has the second deadliest outbreak in the world, behind the United States, with at least 115,914 deaths, according to data compiled by Johns Hopkins University.
A source familiar with the situation told Reuters that the trial would have been suspended if the volunteer had been a part of the group getting the shot.
The news comes as the Food and Drug Administration still has a late-stage clinical trial from AstraZeneca on hold in the United States. That means the company is unable to administer second doses of its two-dose vaccine regimen to U.S. participants.
The company announced on Sept. 8 that its trial had been put on hold due to an unexplained illness in a patient in the United Kingdom. The patient is believed to have developed inflammation of the spinal cord, known as transverse myelitis. The trial has since resumed in the U.K. and other countries.
The U.S. is expected to resume the trial as early as this week after the FDA completed its review, Reuters reported Tuesday, citing four anonymous sources.
AstraZeneca is one of four drugmakers backed by the U.S. in late-stage testing for a potential vaccine. AstraZeneca’s vaccine, called AZD1222, uses genetic material from the coronavirus with a modified adenovirus.
In July, the company published data that showed its vaccine produced a promising immune response in an early-stage trial and appeared to be well tolerated.
The vaccine produced no serious adverse events in volunteers, according to the researchers at the time. Fatigue and headache were the most commonly reported side effects, they said. Other common side effects included pain at the injection site, muscle ache, chills and a fever.
##https://www.cnbc.com/2020/10/21/astrazeneca-shares-slide-after-brazilian-health-authority-says-volunteer-in-covid-vaccine-study-dies.html
Stock
2020-10-14 22:17 | Report Abuse
So naive....
Still looking chart....
Stock
2020-10-14 22:16 | Report Abuse
Aiyo...Finally Karma Idiot come out to give speech...
When can you come to Keyman188 ' listing to give speech!!!!!!
Not only Genting need you Karma Idiot......
Others also need you....
Don't be coward always talking same pattern here lahhh....
Come come come Karma Idiot, give chance Keyman188 collect more besides Genting...
Kekeke
Kekeke.....
Stock
2020-10-14 22:11 | Report Abuse
Keyman188 still can't understand worrr....
But Keyman188 can understand not interested.......
Kekeke....kekeke......
Stock
2020-10-14 21:48 | Report Abuse
So naive....
Who said Hextar controlling Ruberex!!
Please lah....don't spread fake news lah....
Hextar boss himself just controlling Ruberex....
Nothing related to Hextar lahhh....
Despite Keyman188 still holding Hextar but not hungry & hurry to dispose it......
Stock
Stock
2020-10-14 20:42 | Report Abuse
Wahhh....... Siapa fucker Idiot keep on spamming......
Aiyo.....if already stuck Kanger then Kangdoi lorry......
Don't spam so much.......
SOON KARMA WILL VISIT YOU......
Stock
Stock
2020-10-14 20:37 | Report Abuse
Keyman188 average price was 9.60...
So any chance to get 9.00?..
Stock
2020-10-14 20:34 | Report Abuse
So naive......
Kesian....kesian......
People already eaten full baru cakap buy call......
Kesian......kesian......
Stock
2020-10-14 20:30 | Report Abuse
So naive....
Keyman188 worry you your hati will say " Haiz"...
Stock
2020-10-14 18:49 | Report Abuse
Ruberex -vs- Genting
没有更高，只是更加高 -vs- 没有更低，只有更加低
Stock
Stock
2020-10-14 18:33 | Report Abuse
Tomorrow you can see sence can talk or not....kekeke...
Correction come to visit you....
Despite Keyman188 still holding (curi curi tell you, this is Keyman188 3rd round)......
Tapi worrr...Keyman188 tak perlu chart lahhhh for this counter......
Kekeke......
Stock
2020-10-14 18:24 | Report Abuse
Aiyo...Keyman188 forgot to call Karma Idiot come out give speech...
Where are you Karma Idiot...Don't be shy hiding......
When can you come to Keyman188 ' listing to give speech!!!!!!
Not only Genting need you Karma Idiot......
Other also need you....
Stock
2020-10-14 18:20 | Report Abuse
Good stockeeper....
Bursa need you...
Genting need you....
Stock
2020-10-14 18:19 | Report Abuse
lagi nak guna chart to trade!!!!!!
So naive.......
Stock
Stock
2020-10-14 18:12 | Report Abuse
没有更低，只有更加低
没有更惨，只有更加惨
kekeke...
Stock
2020-10-14 18:06 | Report Abuse
Kesian....kesian...kesian...everyday getting lower & lowest....
Despite Keyman188 still holding Genting but also know how to shift to others....
Always Genting....Genting...Genting...not damn boring mehhh......
You see Ruberex today...break record high......
Keyman188 sold all Ruberex @ average 8.01......
Still so stubborn guardian this......
Lucky Keyman188 made the right decision......
Wake up lorrrr......
Stock
2020-10-12 16:18 | Report Abuse
Aiyo...suddenly not much swing liao...
Fantastic counter....cheersss.............
Stock
2020-10-12 16:15 | Report Abuse
Aiyo...everyday Genting...Genting...Genting...Not boring mehhh...
Other players already shifted to other eating full full lorr...
Still waiting until loss other golden opportunities...
Despite Keyman188 still holding but must know how to diversify resources...
Don't always perceive "Last Time Hero Not Necessary Next Time Also Hero"...
Spending so much time on 1 counter end up...hmmmm...hmmm....
Kekekek...kekeke...kekeke...
Stock
2020-10-12 08:42 | Report Abuse
Aiyo...Why Karma Idiot hasn't come to Keyman188 favour counters talk 3 talk 4 talk cock!!!!!
Keyman188 still waiting Karma Idiot here...
HLBB
HLFG
PETGAS
YINSON
MPI
DUFU
UWC
Dpharma
Axiata
IJM
GAMUDA
ETC......
Don't be so coward lahhhh...Karma Idiot....
Come to Keyman188 lists so give more chance to collect more....
Always Genting, super damn boring...kekeke...kekeke...
## Sound like familiar...comments seem familiar...kekeke...kekeke
-----------------------------------------------------------------
If not enough fund, simple just borrow money from bank lahhh...since interest rate so low...
Karma Idiot doesn't attend Saham Sifu course mehhh...Guide you how to do margin of financing to boost up your shareholding...
Heee...heee...heee...
Stock
2020-10-10 23:58 | Report Abuse
Aiya...sure no chance lahhh....all Hollywood & Bollywood show......
Stock
2020-10-10 23:50 | Report Abuse
Aiyo...Why Karma Idiot hasn't come to Keyman188 favour counters talk 3 talk 4 talk cocktails!!!!!
Keyman188 still waiting Karma Idiot here...
HLBB
HLFG
PETGAS
YINSON
MPI
DUFU
UWC
Dpharma
Axiata
IJM
GAMUDA
ETC......
Don't be so coward lahhhh...Karma Idiot....
Come to Keyman188 lists so give more chance to collect more....
Always Genting, super damn boring...
Stock
2020-10-10 18:08 | Report Abuse
Aiyo...why so worry this Karma Idiot talk 3 talk 4 talk cock......
You all should happy when the share price coming lower & lowest...
So give you chance to collect more...
In fact Keyman188 always collecting right counters for long term growth...
Keyman188 still accumulating valuable stocks since share price decelerating......(not only Genting, but also other more potential growth like HLFG...IJM...Padini...Duopharma...Tenaga...Axiata...Petgas...Serbadk...etc)...
Should be happy boombeebee....
## Fyi, this Karma Idiot only talk 3 talk 4 talk cock at this Genting only, because this Karma Idiot scare to talk other counters forum
Stock
2020-10-08 15:09 | Report Abuse
Genting Cruise Lines approved for Singapore safe cruise pilot
(October 08, 2020 13:10 pm +08)
SINGAPORE (Oct 8): In line with the calibrated resumption of economic activities in Singapore amid the Covid-19 pandemic, safe cruises will be piloted from November 2020 with enhanced safety protocols for two cruise lines home ported here, said the Singapore Tourism Board (STB). Genting Cruise Lines and Royal Caribbean International were approved for the pilot.
To allow time to review the operationalisation of enhanced safety protocols, STB said the pilot cruises will start from Nov 6 with Genting Cruise Lines’ World Dream while Royal Caribbean International’s Quantum of the Seas will begin sailing in December.
“This cruise pilot is a valuable opportunity for cruise operators to reinvent the entire cruise experience in order to regain the confidence of passengers,” said STB chief executive Keith Tan in a statement here today.
To assure safe cruising, STB is developing a mandatory CruiseSafe certification programme, which sets out stringent hygiene and safety measures throughout the passenger journey — from before boarding, to after disembarkation.
STB said the pilot cruises will be round-trips with no ports of call, sailing at a reduced capacity of up to 50% and only open to Singapore residents.
The Singapore government will monitor the outcomes of the pilot sailings carefully in the coming months before deciding on the next steps for cruises, it said.
“As ASEAN’s lead coordinator for cruise development, Singapore remains committed to supporting and growing cruise tourism in the region. We will continue to work with cruise lines and our industry stakeholders to chart a new course for safe cruising,” said Tan.
To prepare for the eventual recovery of the cruise industry, STB has also partnered Cruise Lines International Association (CLIA) and Travel Weekly Asia to hold a series of training webinars for regional travel agents under the ambit of CruiseWorld Asia 2020.
According to STB, travel agents are key to the industry, accounting for about 80% of cruise packages sold in the region.
Training sessions will take place in October and focus on strengthening consumers’ confidence to cruise again by raising awareness of cruise lines’ enhanced sanitisation measures onboard and rebuilding the demand for cruise, it said.
##https://www.theedgemarkets.com/article/genting-cruise-lines-approved-singapore-safe-cruise-pilot
Stock
2020-10-07 23:44 | Report Abuse
If tomorrow up above 0.15...
Keyman188 group standby to sell 5 millions share to operators....
Stock
2020-10-07 23:38 | Report Abuse
Terrible nowadays....so many conman....
Using other stock news to cheat forumers every way....
Memang Malaysia always BOLEH.....
Stock
2020-10-07 14:26 | Report Abuse
Very soon sailing back to 0.035...
Skim Cepat Kaya......sooner & later....Skim Lambat Mampus......
Stock
2020-10-07 13:22 | Report Abuse
Too sad to say, Keyman188 didn't invest or bet this counter...
Let newbies join the party better....
Later let Keyman188 watching ppl here huuhaa better....
But later don't blame here blame there....kekeke
Stock
2020-10-07 11:19 | Report Abuse
Hmmmmmmmmmm.................
Woooooooooo.................
Skim Cepat Kaya -vs- Skim Lambat Mampus
Stock
2020-10-07 08:45 | Report Abuse
Aiyahh...
Whatever lahhh......Not Keyman188 money...
Just pity people kena tipu only......
Forum created is free to talk...you can talk...he can talk..they can talk...
kekeke...kekeke...kekeke...
Stock
2020-10-07 08:34 | Report Abuse
Data will not lie (unless report manipulated) but only people can lie...
Naim - nett debt RM 275 million
Dayang - nett debt RM 353 million
Perdana - nett debt RM 58 million
Oh my god......really don't know what to say liao....hehehe..hehehe...
Stock
2020-10-07 08:23 | Report Abuse
very good dreamer...
Skim cepat kaya -vs- Skim lambat mampus...
Stock
2020-10-07 08:19 | Report Abuse
Kesian...kesian...to newbies....
For the last years until 1st half of this year.......
This stock is part of Keyman188's darling counter......
But now Keyman188 didn't touch again, you now why...
1st - sunset business without further growing
2nd - illegal market still spiking above 60% market share until unable solve it
3rd - Nett debt keep on growing until now RM 518 million outstanding debt...
** Don't forget, if 1 day company wants to pare down outstanding debt by stopping dividend payout, sure trapping a lot of investors
Stock
2020-10-07 08:06 | Report Abuse
Furthermore, currently company nett debt about RM 275 million...
Supposing should use whatever income from the disposal to pare down the debt is the best choice......
Don't forget AirAsia lesson from last year July !!!
AirAsia disposed all aircraft then given special dividend to shareholder, so what happening now......
Nowadays market uncertainty due to virus pandemic & still spiking level...
The best choice is the company how to secure the cash pile & pare down debt so much as possible...
In fact, Keyman188 really pity newbies always have been trapped by lack of knowledge on the stock markets...
Kesian...kesian...
Stock
2020-10-07 07:55 | Report Abuse
Aiyo...only 1 time payment from the income of land disposal.....
Some more the stock price also can adjust by accordingly 18 sen later on the ex-date......
Later investing because of 1 time dividend then lock in by stagnant level......
Aiyo.... not worthy lahhh......
Stock: [GENTING]: GENTING BHD
2020-10-22 11:27 | Report Abuse
别人笑我太疯癫
我笑他人看不出穿
People laugh at me too crazy
I laugh at others can’t see thoroughly
kekeke...kekeke...kekeke...